Suiram schreef op 28 juli 2014 23:00:
Een antwoord van dhr. Sijmen op een e-mail hem gestuurd door een Fransosische medebelegger (ter info):
www.boursorama.com/forum-pharming-grp...Inhoud (in Hollands steenkolenengels):
Dear Mr. X,
Thank you very much for your patience and support.
Now that we have achieved this important milestone, we will indeed be working on getting more support from institutional shareholders and getting the "story" in front of many of these that did not want to take a look at it prior to the approval. We will indeed communicate news and plans as and when we have it, but wil continue to refrain from creating hype. Please realise that it is not unusual for share prices to reverse (for some period of time) after good news.
Last but not least, please realise that we have now gained access to a market that can make the difference in commercial fundamentals for the company as well, such that eventually the proceeds from future sales may exceed our costs basis!
Trust this information is helpful,
Kind regards / Met vriendelijke groet,
Sijmen de Vries, MD MBA
Chief Executive Officer
Pharming Group NV
Darwinweg 24 | 2333CR Leiden | The Netherlands